SCHEMBL4929645

SCHEMBL4929645

CN1CCN(Cc2cc(NC(=O)Nc3ccc(Oc4cc(Cl)ncn4)cc3)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.65
BRAF P15056 11/20 0.65
FGFR1 P11362 2/20 0.62
MAPK14 Q16539 11/20 0.58
TNNI3K Q59H18 10/20 0.58
SRC P12931 3/20 0.51
CDK2 P24941 2/20 0.51
CDK8 P49336 2/20 0.51
ABL1 P00519 2/20 0.51
CDK1 P06493 1/20 0.51
STK25 O00506 1/20 0.51
CIT O14578 1/20 0.51
MAP2K7 O14733 1/20 0.51
IKBKB O14920 1/20 0.51
AURKA O14965 1/20 0.51
GAK O14976 1/20 0.51
CHUK O15111 1/20 0.51
MUSK O15146 1/20 0.51
MAPK13 O15264 1/20 0.51
MAP3K13 O43283 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3173197 0.93 KDR (0.59) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4932639 0.92 KDR (0.64) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4935608 0.91 KDR (0.56) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4769351 0.91 KDR (0.64) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4769465 0.90 KDR (0.65) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4769716 0.85 MAP3K7 (0.55) KDRBRAFMAPK14TNNI3KMAP3K7
SCHEMBL4937797 0.84 SRC (0.72) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4937968 0.83 KDR (0.69) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4932660 0.83 KDR (0.66) KDRBRAFFGFR1MAPK14TNNI3K
SCHEMBL4771607 0.83 KDR (0.70) KDRBRAFFGFR1MAPK14TNNI3K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA KDR 1309/4885BRAF 65/4885FGFR1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.